Abstract |
The reported incidence of anastomotic stricture after esophageal atresia repair has varied in case series from as low as 9% to as high as 80%. The cornerstone of esophageal stricture treatment is dilation with either balloon or bougie. The goal of esophageal dilation is to increase the luminal diameter of the esophagus while also improving dysphagia symptoms. Once a stricture becomes refractory to esophageal dilation, there are several treatment therapies available as adjuncts to dilation therapy. These therapies include intralesional steroid injection, mitomycin C, esophageal stent placement, and endoscopic incisional therapy.
|
Authors | Michael A Manfredi |
Journal | Gastrointestinal endoscopy clinics of North America
(Gastrointest Endosc Clin N Am)
Vol. 26
Issue 1
Pg. 201-19
(Jan 2016)
ISSN: 1558-1950 [Electronic] United States |
PMID | 26616905
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2016 Elsevier Inc. All rights reserved. |
Chemical References |
- Alkylating Agents
- Steroids
- Mitomycin
|
Topics |
- Alkylating Agents
(therapeutic use)
- Deglutition Disorders
(etiology, surgery)
- Dilatation
(methods)
- Esophageal Atresia
(complications)
- Esophageal Stenosis
(etiology, therapy)
- Esophagoscopy
(instrumentation, methods)
- Esophagus
(surgery)
- Humans
- Injections, Intralesional
- Mitomycin
(therapeutic use)
- Stents
- Steroids
(administration & dosage)
|